$DFTX The Latest Data on Psychedelic DT120 ODT With Daniel R. Karlin, MD, MA
Videos|April 27, 2026
https://www.psychiatrictimes.com/view/the-lat...rlin-md-ma
Daniel R. Karlin, MD, MA, the chief medical officer of Definium Therapeutics, shared some more information about the data on DT120 and what separates it from other psychedelics, including the new information shared at their Investor and Analyst Day.
Videos|April 27, 2026
https://www.psychiatrictimes.com/view/the-lat...rlin-md-ma
Daniel R. Karlin, MD, MA, the chief medical officer of Definium Therapeutics, shared some more information about the data on DT120 and what separates it from other psychedelics, including the new information shared at their Investor and Analyst Day.